Point72 Asia (Singapore)’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-54,174	Closed	-$139K	–	1181
2025 Q1	$139K	Buy	54,174 +667	+1%	+$1.71K	0.04%	342
2024 Q4	$101K	Buy	53,507 +6,434	+14%	+$12.1K	0.03%	368
2024 Q3	$48K	Sell	47,073 -21,090	-31%	-$21.5K	0.01%	700
2024 Q2	$79.8K	Buy	+68,163	New	+$79.8K	0.02%	541